All Data Related To Interim Results From The Coronavirus (Covid-19) Infection Survey
All Data Related To Interim Results From The Coronavirus (Covid-19) Infection Survey. Early management information from the coronavirus (covid. The solidarity trial is an adaptive trial.
Our main variant analysis is for a reference day, and therefore is not directly comparable with the sequencing data. Early management information from the coronavirus (covid. Strengths and limitations for more details. The following analysis looks at. The start dates for this analysis relate to when the survey started, which is different for each country, and the analysis goes up to 11 february 2022. Measuring the data and section 12: Technical dataset includes analysis of the genetic lineages of coronavirus seen in the sequenced samples (see notes 15 and 16). Estimates for england, wales, northern ireland and scotland. The solidarity trial is an adaptive trial. All data are provisional and subject to revision.
Hydroxychloroquine and lopinavir/ritonavir arms were discontinued on 20 june and 4 july. Estimates for england, wales, northern ireland and scotland. Dataset | released on 10 june 2022. 25 to 31 december 2021 24 december 2021 an interim release of the latest data from the coronavirus (covid. Technical dataset includes analysis of the genetic lineages of coronavirus seen in the sequenced samples (see notes 15 and 16). Since march 2022, omicron ba.2 compatible infections have been the most common in all uk countries. Since march 2022 omicron ba.2 compatible infections have been the most common in all uk countries. This means that some unpromising drugs have been dropped and others will be added. Early management information from the coronavirus (covid. The findings set out in this report relate to estimates for ni for the week beginning 14 march 2022.